These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 8073808)

  • 21. [Severe pneumonitis as a complication of low-dose methotrexate therapy in psoriasis-associated polyarthritis].
    Schnabel A; Gross WL
    Dtsch Med Wochenschr; 1995 Sep; 120(36):1223-5. PubMed ID: 7671777
    [No Abstract]   [Full Text] [Related]  

  • 22. Psoriatic arthritis and methotrexate.
    Borges NE; Vaidya S
    J Assoc Physicians India; 1994 Nov; 42(11):859. PubMed ID: 7868483
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recommendations for the appropriate use of anti-TNFalpha therapy in patients with psoriatic arthritis. Italian Rheumatology Society].
    Salvarani C; Olivieri I; Cantini F; Marchesoni A; Punzi L; Scarpa R; Matucci-Cerinic M
    Reumatismo; 2004; 56(3):133-4, 136-8. PubMed ID: 15470517
    [No Abstract]   [Full Text] [Related]  

  • 24. Psoriatic onycho-pachydermo-periostitis successfully treated with low-dose methotrexate.
    Ochiai T; Washio H; Shiraiwa H; Takei M; Sawada S
    Med Sci Monit; 2006 Apr; 12(4):CS27-30. PubMed ID: 16572055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Psoriatic onycho-pachydermo- periostitis].
    Kroiss MM; Vogt T; Finkenzeller T; Landthaler M; Stolz W
    Z Rheumatol; 2002 Oct; 61(5):598-600. PubMed ID: 12399889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Voltaren gel in the combined treatment of patients with psoriatic arthritis].
    Shakhtmeĭster IIa; Kamennykh EV
    Vestn Dermatol Venerol; 1990; (10):55-7. PubMed ID: 2278198
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methotrexate in psoriatic polyarthritis.
    Ranza R; Marchesoni A; Rossetti A; Tosi S; Gibelli E
    J Rheumatol; 1993 Oct; 20(10):1804-5. PubMed ID: 8295201
    [No Abstract]   [Full Text] [Related]  

  • 28. [Adult onset Still's disease (AOSD) treated with a combination of prednisolone, cyclosporin A, and methotrexate].
    Sasaki R; Shiba H; Kin M; Ohyama M; Yamana J; Yamana S
    Ryumachi; 2003 Oct; 43(4):649-53. PubMed ID: 14598657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination].
    Danieli MG; Fratini M; Rossetti L; Giovagnoni A; Amici F; Danieli G
    Recenti Prog Med; 1998 Jan; 89(1):7-13. PubMed ID: 9549386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generalized pustular psoriasis following withdrawal of short-term cyclosporin therapy for psoriatic arthritis.
    Hong SB; Kim NI
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):522-3. PubMed ID: 15987319
    [No Abstract]   [Full Text] [Related]  

  • 31. Longterm therapy of psoriatic arthritis: intramuscular gold or methotrexate?
    Lacaille D; Stein HB; Raboud J; Klinkhoff AV
    J Rheumatol; 2000 Aug; 27(8):1922-7. PubMed ID: 10955334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine and tacrolimus for the treatment of rheumatoid arthritis.
    Kitahara K; Kawai S
    Curr Opin Rheumatol; 2007 May; 19(3):238-45. PubMed ID: 17414949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register.
    Kristensen LE; Gülfe A; Saxne T; Geborek P
    Ann Rheum Dis; 2008 Mar; 67(3):364-9. PubMed ID: 17644547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low prescription rate for systemic treatments in the management of severe psoriasis vulgaris and psoriatic arthritis in dermatological practices in Berlin and Brandenburg, Germany: results from a patient registry.
    Nast A; Reytan N; Rosumeck S; Erdmann R; Rzany B
    J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1337-42. PubMed ID: 18624864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Soluble interleukin-2 receptor and interleukin-6 levels: evaluation during cyclosporin A and methotrexate treatment in psoriatic arthritis.
    Spadaro A; Taccari E; Sensi F; Riccieri V; Sili Scavalli A; Zoppini A
    Clin Rheumatol; 1998; 17(1):83-5. PubMed ID: 9586691
    [No Abstract]   [Full Text] [Related]  

  • 36. Termination of disease-modifying antirheumatic drugs in rheumatoid arthritis and in psoriatic arthritis. A comparative study of 270 cases.
    Ujfalussy I; Koó E; Seszták M; Gergely P
    Z Rheumatol; 2003 Apr; 62(2):155-60. PubMed ID: 12721703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accelerated pulmonary nodulosis and sterile pleural effusion in a patient with psoriatic arthropathy during methotrexate therapy: a case report.
    Balbir-Gurman A; Guralnik L; Best LA; Vlodavsky E; Yigla M; Menahem Nahir A; Braun-Moscovici Y
    J Clin Rheumatol; 2009 Feb; 15(1):29-30. PubMed ID: 18679135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serious pancytopenia from methotrexate treatment of psoriatic arthritis.
    Chang YC; Chen JD; Yen DH; Wang LM; Huang CI; Lee CH
    Am J Emerg Med; 2006 May; 24(3):392-4. PubMed ID: 16635735
    [No Abstract]   [Full Text] [Related]  

  • 39. [Gold preparations in therapy of rheumatoid and psoriatic arthritis].
    Nasonova VA; Lukina GV; Sigidin IaA; Badokin VV
    Ter Arkh; 2003; 75(5):88-90. PubMed ID: 12847908
    [No Abstract]   [Full Text] [Related]  

  • 40. Treatment of psoriatic arthritis and rheumatoid arthritis with disease modifying drugs -- comparison of drugs and adverse reactions.
    Helliwell PS; Taylor WJ;
    J Rheumatol; 2008 Mar; 35(3):472-6. PubMed ID: 18203324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.